Johannes Kepler Universität Linz

11/17/2023 | Press release | Distributed by Public on 11/17/2023 02:44

Watch the 7th JKU medTALK

Funded by an Austrian Research Promotion Agency (FFG) grant, the AIMS project will improve patient safety using artificial intelligence.

From left: Lukas Madl, Jens Meier, Elgin Drda, Michael Giretzlehner, Patrick Haidinger and Christine Haiden; Photo credit: JKU

Funded by an Austrian Research Promotion Agency (FFG) grant, the AIMS (Artificial Intelligence Based Monitoring and Early Warning for Patient Safety) project will improve patient safety using artificial intelligence.

Despite the fact that surgical procedures today are safer than ever before, they still carry a high level of risk for patients. In Europe, on average, 4% of all patients undergoing surgery die in hospital. 2-3% pass away in a normal ward without having been admitted to an ICU. A considerable percentage of these patients die unexpectedly. The AIMS research project will address this issue and seek to improve patient safety.
The 7th JKU medTALK focused on the opportunities this technology presents as well as the resulting ethical questions

At the podium:

  • Univ. Prof. Dr. Jens Meier, head of the Department of Anaesthesiology and Surgical Intensive Care Medicine, and head of the Department of Neuroanaesthesia and Intensive Care Medicine at KUK, JKU
  • Dr. Michael Giretzlehner, head of Research Department of Medical Informatics, RISC Software Ltd.
  • Mag. Lukas Madl, geneticist and managing director at innovethic
  • Patrick Haidinger, co-founder and CTO of FiveSquare Ltd.

Moderator:

Dr. Christine Haiden, journalist and President of the Upper Austrian Press Club

Click here to watch the 7th JKU medTALK: https://youtu.be/bPO2XK3L4t8, opens an external URL in a new window

The JKU medTALK series at the Johannes Kepler University Linz takes places at the new JKU medLOFT center and focuses on future topics in medicine. The medTALK series is an opportunity for the JKU to provide a quarterly platform to support research and innovation in medicine as well as give medical professionals, media experts, and representatives in medical industries an opportunity discuss various contemporary, and sometime controversial, issues.